Functional microRNA binding site variants

by Ye Yuan, Joanne B. Weidhaas
Published 2019-01-01

Breast Cancer and miR-SNPs: The Importance of miR Germ-Line Genetics

by Poonam Malhotra, Graham H. Read, Joanne B. Weidhaas
Published 2019-03-01

miR-34 activity is modulated through 5′-end phosphorylation in response to DNA damage

by David W. Salzman, Kotoka Nakamura, Sunitha Nallur, Michelle T. Dookwah, Chanatip Metheetrairut, Frank J. Slack, Joanne B. Weidhaas
Published 2016-03-01

Erratum: The Non-Coding RNA Journal Club: Highlights on Recent Papers—4. Non-Coding RNA 2016, 2, 9

by Daniel Gautheret, Joseph H. Taube, Sendurai A. Mani, Gaetano Santulli, Diego Cuerda-Gil, R. Keith Slotkin, Bo Zhang, Yanli Wang, David W. Salzman, Joanne B. Weidhaas
Published 2016-09-01

The Non-Coding RNA Journal Club: Highlights on Recent Papers—4

by Daniel Gautheret, Joseph H. Taube, Sendurai A. Mani, Gaetano Santulli, Diego Cuerda-Gil, R. Keith Slotkin, Bo Zhang, Yanli Wang, David W. Salzman, Joanne B. Weidhaas
Published 2016-09-01

The KRAS-variant is associated with risk of developing double primary breast and ovarian cancer.

by Robert Pilarski, Divya A Patel, Jeffrey Weitzel, Terri McVeigh, Jemima J Dorairaj, Helen M Heneghan, Nicola Miller, Joanne B Weidhaas, Michael J Kerin, Megan McKenna, Xifeng Wu, Michelle Hildebrandt, Daniel Zelterman, Sharon Sand, Lee P Shulman
Published 2012-01-01

Development and Validation of a Comprehensive Multivariate Dosimetric Model for Predicting Late Genitourinary Toxicity Following Prostate Cancer Stereotactic Body Radiotherapy

by Luca F. Valle, Dan Ruan, Audrey Dang, Rebecca G. Levin-Epstein, Ankur P. Patel, Joanne B. Weidhaas, Nicholas G. Nickols, Percy P. Lee, Daniel A. Low, X. Sharon Qi, Christopher R. King, Michael L. Steinberg, Patrick A. Kupelian, Minsong Cao, Amar U. Kishan
Published 2020-05-01

Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

by Davide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, Rongze Lu, Karolina Palucka, Josue Samayoa, Stefani Spranger, Sarah Warren, Kwok-Kin Wong, Elad Ziv, Diego Chowell, Lisa M. Coussens, Daniel D. De Carvalho, David G. DeNardo, Jérôme Galon, Howard L. Kaufman, Tomas Kirchhoff, Michael T. Lotze, Jason J. Luke, Andy J. Minn, Katerina Politi, Leonard D. Shultz, Richard Simon, Vésteinn Thórsson, Joanne B. Weidhaas, Maria Libera Ascierto, Paolo Antonio Ascierto, James M. Barnes, Valentin Barsan, Praveen K. Bommareddy, Adrian Bot, Sarah E. Church, Gennaro Ciliberto, Andrea De Maria, Dobrin Draganov, Winson S. Ho, Heather M. McGee, Anne Monette, Joseph F. Murphy, Paola Nisticò, Wungki Park, Maulik Patel, Michael Quigley, Laszlo Radvanyi, Harry Raftopoulos, Nils-Petter Rudqvist, Alexandra Snyder, Randy F. Sweis, Sara Valpione, Roberta Zappasodi, Lisa H. Butterfield, Mary L. Disis, Bernard A. Fox, Alessandra Cesano, Francesco M. Marincola, Society for Immunotherapy of Cancer (SITC) Cancer Immune Responsiveness Task Force and Working Groups
Published 2019-05-01

Correction to: Toward a comprehensive view of cancer immune responsiveness: a synopsis from the SITC workshop

by Davide Bedognetti, Michele Ceccarelli, Lorenzo Galluzzi, Rongze Lu, Karolina Palucka, Josue Samayoa, Stefani Spranger, Sarah Warren, Kwok-Kin Wong, Elad Ziv, Diego Chowell, Lisa M. Coussens, Daniel D. De Carvalho, David G. DeNardo, Jérôme Galon, Howard L. Kaufman, Tomas Kirchhoff, Michael T. Lotze, Jason J. Luke, Andy J. Minn, Katerina Politi, Leonard D. Shultz, Richard Simon, Vésteinn Thórsson, Joanne B. Weidhaas, Maria Libera Ascierto, Paolo Antonio Ascierto, James M. Barnes, Valentin Barsan, Praveen K. Bommareddy, Adrian Bot, Sarah E. Church, Gennaro Ciliberto, Andrea De Maria, Dobrin Draganov, Winson S. Ho, Heather M. McGee, Anne Monette, Joseph F. Murphy, Paola Nisticò, Wungki Park, Maulik Patel, Michael Quigley, Laszlo Radvanyi, Harry Raftopoulos, Nils-Petter Rudqvist, Alexandra Snyder, Randy F. Sweis, Sara Valpione, Roberta Zappasodi, Lisa H. Butterfield, Mary L. Disis, Bernard A. Fox, Alessandra Cesano, Francesco M. Marincola, Society for Immunotherapy of Cancer (SITC) Cancer Immune Responsiveness Task Force and Working Groups
Published 2019-07-01